Orthofix stock.

SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ...Date Filing Type Filing Description Download / View. Nov 21, 2023. 4. Statement of Changes in Beneficial Ownership. Nov 20, 2023. 144. Report of proposed sale of securities. Nov 09, 2023. 144.Shares of Orthofix Medical (. OFIX Quick Quote. OFIX - Free Report) have plunged 4.5% since the release of its third-quarter earnings on Nov 8. The company delivered third-quarter 2023 adjusted ...Orthofix Medical Inc. OFIX shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, effective prior to the …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...

October 12, 2023 - 7:00 am. LEWISVILLE, Texas Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove ™, an advanced bioactive synthetic graft. Available in both a putty and strip configuration, OsteoCove was carefully formulated to provide ...5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ...

Orthofix Medical Inc. (NASDAQ:OFIX) entered into a new four-year financing agreement with a borrowing capacity of up to $150 million. The company reported net sales of $184.0 million, a 61% increase on a reported basis and an 8% increase on a pro forma basis. Adjusted EBITDA was $13.5 million, representing 36% sequential growth over the …

October 11, 2022 By Danielle Kirsh. Orthofix (Nasdaq:OFIX) and SeaSpine (Nasdaq:SPNE) today announced a definitive agreement to combine companies in an all-stock merger of equals. Under the terms ...As announced on October 11, 2022, Orthofix and SeaSpine agreed to combine in an all-stock merger of equals. The transaction is expected to close in the first quarter of 2023 subject to Orthofix and SeaSpine shareholder approvals andother customary closing conditions. About OrthofixAccording to the issued ratings of 3 analysts in the last year, the consensus rating for Orthofix Medical stock is Hold based on the current 3 hold ratings for OFIX. The average twelve-month price prediction for Orthofix Medical is $14.00 with a high price target of $16.00 and a low price target of $12.00. Learn more on OFIX's analyst rating ...Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corporation (NYSE: ENOV). At that time, Mr. Calafiore is also expected to join ...

SeaSpine shares ceased trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern time on January 4, 2023, and holders of SeaSpine common stock are receiving 0.4163 shares of Orthofix common ...

Orthofix Medical has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.

Stock analysis for Orthofix Medical Inc (OFIX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Third quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments Biologics net sales growth of 8% driven by new product introductions Bone Growth Therapies net sales growth of 3% driven by the commercial roll-out of ...If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ...Orthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’ (MarketWatch) Orthofix Medical Inc. investors suffered their worst day in nearly 30 years on Tuesday, after the spine and orthopedics company fired three top executives “for cause.”. The company OFIX, 2.31% said following an ...OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a price/earnings ratio of 45.96, and a dividend yield of 0%. See the latest news, financials, valuations, and sustainability of OFIX on Morningstar.About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.Orthofix Medical Stock Performance OFIX stock opened at $11.12 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.58 and a debt-to …

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.There is no cost or obligation to you. New York, New York-- (Newsfile Corp. - November 6, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national …“Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics.Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript November 8, 2023 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.77471 EPS, expectations were $-0.22. Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call.New York, New York--(Newsfile Corp. - November 9, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such ...Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine …

Orthofix will report its full financial results for 2021 and provide its financial outlook for 2022 during its earnings announcement planned for February 25, 2022. About Orthofix Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus.LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)-- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement ...

Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.Real time Orthofix Medical (OFIX) stock price quote, stock graph, news & analysis. The average price point forecasted by analysts for Orthofix Medical Inc (OFIX) is $20.50, which is $9.87 above the current market price. The public float for OFIX is 35.34M, and currently, short sellers hold a 4.26% ratio of that floaft. The average trading volume of OFIX on November 10, 2023 was 630.17K shares. OFIX) stock’s […]LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today …Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF). Published in TheSpine Journal, patients treated with the M6-C disc ...Sep 12, 2023 · Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Boa Jan 4, 2023 · SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ...

Orthopedics. Orthofix offers innovative and minimally invasive extremity solutions to help surgeons improve their patient’s quality of life. Designed to address the lifelong bone and joint health needs of patients of all ages, our orthopedics products help patients achieve a more active and mobile lifestyle when compared to other surgical solutions.

Under the terms of the agreement, which was unanimously approved by the Boards of Directors of both companies, SeaSpine shareholders will receive 0.4163 shares of Orthofix common stock for each ...

The stock sells at ~1x forward sales and has created marginal value above its net asset value ($1.12 for every $1 invested, to be precise). Investors have priced the company at just 1.12x the ...Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Oct 11, 2022 · LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)-- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement ... If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Orthofix Medical Inc. announced that Massimo Calafiore has been named incoming President. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate?s previously announced acquisition by Enovis …Orthofix appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release ...Orthofix Medical Inc. Stock technical analysis with dynamic chart and Delayed Quote | Deutsche Boerse AG: OM2 | Deutsche Boerse AGOrthofix Medical has a market cap or net worth of $413.88 million as of November 29, 2023. Its market cap has increased by 23.58% in one year. ... is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding. Formula: Market Cap = Stock Price * Shares ...Orthofix is a leading medical device company and provider of spinal, orthopedic, bone growth, and motion preservation products since 1980.Description. Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair ...Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today. Of votes cast, 99% of SeaSpine common shares were voted in …

Orthofix will report its full financial results for 2021 and provide its financial outlook for 2022 during its earnings announcement planned for February 25, 2022. About Orthofix Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus.Orthofix Medical Inc (NASDAQ: OFIX)’s stock price has increased by 3.15 compared to its previous closing price of 10.49. However, the company has seen a 11.66% increase in its stock price over the last five trading sessions. Seeking Alpha reported 2023-11-08 that Orthofix Medical Inc. (NASDAQ:OFIX ) Q3 2023 Earnings Call Transcript November 8, 2023 […]There is no cost or obligation to you. New York, New York-- (Newsfile Corp. - November 6, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national …Instagram:https://instagram. earn stock dividendbest banking stocksbest offshore forex brokers that accept us clientsberger montague pc All these institutional investors and hedge funds hold approximately 88.71% of Orthofix Medical’s stock currently. This level of ownership suggests confidence among major players within the industry regarding the potential growth and profitability of Orthofix Medical. In terms of financial performance on August 2nd, OFIX opened at $19.82 per ...Sep 10, 2023 · The stock sells at ~1x forward sales and has created marginal value above its net asset value ($1.12 for every $1 invested, to be precise). Investors have priced the company at just 1.12x the ... compute portfolio betafarmland reits The Orthofix International N.V. stock price gained 0.267% on the last trading day (Wednesday, 29th Nov 2023), rising from $11.23 to $11.26. During the last trading day the stock fluctuated 2.93% from a day low at $11.25 to a day high of $11.58. The price has risen in 8 of the last 10 days and is up by 7.6% over the past 2 weeks.5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ... uptd stock Orthofix’s recent financial performance also informs the Hold rating. While the company has shown some growth, with a modest year-over-year increase in sales, it has …Orthofix Medical had revenue of $668.46M in the twelve months ending September 30, 2023, with 44.20% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $184.01M with 61.41% year-over-year growth. In the year 2022, Orthofix Medical had annual revenue of $460.71M, a decrease of -0.81%.